{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:38:33Z","timestamp":1760315913330,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.eplepsyres.2005.04.001","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:46:32Z","timestamp":1118403992000},"page":"117-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero"],"prefix":"10.1016","volume":"65","author":[{"given":"Iiris","family":"Sorri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eila","family":"Herrg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katriina","family":"Viinikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"P\u00e4\u00e4kk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reetta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2005.04.001_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-9926(199703)55:3<165::AID-TERA1>3.0.CO;2-1","article-title":"Teratogenic effects of vigabatrin in TO mouse fetuses","volume":"55","author":"Abdulrazzaq","year":"1997","journal-title":"Teratology"},{"unstructured":"Committee for proprietary medicinal products. Opinion following an article 12 referral. Vigabatrin. (CPMP-report\/1357\/99). The European Agency for the Evaluation of Medicinal Products, 1999. http:\/\/www.emea.eu.int\/pdfs\/human\/phv\/135799en.pdf. 26.10.2001.","key":"10.1016\/j.eplepsyres.2005.04.001_bib2"},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1017\/S0952523800012700","article-title":"Analysis of the distribution of glycine and GABA in amacrine cells of the developing rabbit retina: a comparison with the ontogeny of a functional GABA transport system in retinal neurons","volume":"14","author":"Crook","year":"1997","journal-title":"Visual Neurosci."},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib4","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1002\/ana.20081","article-title":"Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats","volume":"55","author":"Duboc","year":"2004","journal-title":"Annu. Neurol."},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.57.8.1416","article-title":"Randomized trial of vigabatrin in patients with infantile spasms","volume":"57","author":"Elterman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.53.5.922","article-title":"Vigabatrin a gabaergic antiepileptic drug causes concentric visual field defects","volume":"53","author":"K\u00e4lvi\u00e4inen","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samr\u00e9n","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.57.2.196","article-title":"Visual field constriction. Accumulation of vigabatrin but not tiagabine in the retina","volume":"57","author":"Sills","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/B:DOOP.0000005337.39947.83","article-title":"Examining visual field defects in the pediatric population exposed to vigabatrin","volume":"107","author":"Spencer","year":"2003","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.eplepsyres.2005.04.001_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1600-0420.1999.770509.x","article-title":"Visual and ocular outcome in children after prenatal exposure to antiepileptic drugs","volume":"77","author":"Te\u00e4r Fanhehjelm","year":"1999","journal-title":"Acta Ophthalmol. Scand."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:15:05Z","timestamp":1760274905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121105000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":10,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0920121105000744"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.04.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}